<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37065187</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Gut dysbiosis in autoimmune diseases: Association with mortality.</ArticleTitle><Pagination><StartPage>1157918</StartPage><MedlinePgn>1157918</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1157918</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2023.1157918</ELocationID><Abstract><AbstractText>To better understand the impact of gut dysbiosis on four autoimmune diseases [Sj&#xf6;gren's syndrome (SS), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS)], this review investigated the altered gut bacteria in each disease and the shared ones among the four diseases. The enriched gut bacteria shared by three of the four autoimmune diseases were <i>Streptococcus</i>, <i>Prevotella</i>, and <i>Eggerthella</i>, which are associated with autoantibody production or activation of Th17 cells in immune-related diseases. On the other hand, <i>Faecalibacterium</i> comprises depleted gut bacteria shared by patients with SLE, MS, and SS, which is associated with various anti-inflammatory activities. The indexes of gut dysbiosis, defined as the number of altered gut bacterial taxa divided by the number of studies in SLE, MS, RA, and SS, were 1.7, 1.8, 0.7, and 1.3, respectively. Interestingly, these values presented a positive correlation trend with the standardized mortality rates -2.66, 2.89, 1.54, and 1.41, respectively. In addition, shared altered gut bacteria among the autoimmune diseases may correlate with the prevalence of polyautoimmunity in patients with SLE, SS, RA, and MS, that is, 41 percent, 32.6 percent, 14 percent, and 1-16.6 percent, respectively. Overall, this review suggests that gut dysbiosis in autoimmune diseases may be closely related to the failure of the gut immune system to maintain homeostasis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Chang and Choi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Sung-Ho</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Immunology and Molecular Microbiology, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Youngnim</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Immunology and Molecular Microbiology, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sj&#xf6;gren&#x2019;s syndrome</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">gut dysbiosis</Keyword><Keyword MajorTopicYN="N">multiple sclerosis</Keyword><Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>3</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37065187</ArticleId><ArticleId IdType="pmc">PMC10102475</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2023.1157918</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aho K., Koskenvuo M., Tuominen J., Kaprio J. (1986). Occurrence of rheumatoid arthritis in a nationwide series of twins. J. Rheumatol. 13 (5), 899&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">3820198</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander M., Ang Q. Y., Nayak R. R., Bustion A. E., Sandy M., Zhang B., et al. . (2022). Human gut bacterial metabolism drives Th17 activation and colitis. Cell Host Microbe 30 (1), 17&#x2013;30 e19. doi:&#xa0;10.1016/j.chom.2021.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.11.001</ArticleId><ArticleId IdType="pmc">PMC8785648</ArticleId><ArticleId IdType="pubmed">34822777</ArticleId></ArticleIdList></Reference><Reference><Citation>Amador-Patarroyo M. J., Arbelaez J. G., Mantilla R. D., Rodriguez-Rodriguez A., Cardenas-Roldan J., Pineda-Tamayo R., et al. . (2012). Sjogren&#x2019;s syndrome at the crossroad of polyautoimmunity. J. Autoimmun 39 (3), 199&#x2013;205. doi:&#xa0;10.1016/j.jaut.2012.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2012.05.008</ArticleId><ArticleId IdType="pubmed">22749530</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreasen M., Meisl G., Taylor J. D., Michaels T. C. T., Levin A., Otzen D. E., et al. . (2019). Physical determinants of amyloid assembly in biofilm formation. mBio 10 (1), e02279-18. doi:&#xa0;10.1128/mBio.02279-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02279-18</ArticleId><ArticleId IdType="pmc">PMC6325246</ArticleId><ArticleId IdType="pubmed">30622185</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz D., Omarbekova A., Heguy A., Schwudke D., Gisch N., Rovin B. H., et al. . (2019). Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann. Rheum Dis. 78 (7), 947&#x2013;956. doi:&#xa0;10.1136/annrheumdis-2018-214856</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214856</ArticleId><ArticleId IdType="pmc">PMC6585303</ArticleId><ArticleId IdType="pubmed">30782585</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai X., Wei H., Liu W., Coker O. O., Gou H., Liu C., et al. . (2022). Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut 71 (12), 2436&#x2013;2450. doi:&#xa0;10.1136/gutjnl-2021-325021</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325021</ArticleId><ArticleId IdType="pmc">PMC9664112</ArticleId><ArticleId IdType="pubmed">35387878</ArticleId></ArticleIdList></Reference><Reference><Citation>Baka Z., Buzas E., Nagy G.. (2009). Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res. Ther. 11 (4), 238. doi:&#xa0;10.1186/ar2751</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2751</ArticleId><ArticleId IdType="pmc">PMC2745780</ArticleId><ArticleId IdType="pubmed">19678909</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrasso K., Chac D., Debela M. D., Geigel C., Steenhaut A., Rivera Seda A., et al. . (2022). Impact of a human gut microbe on vibrio cholerae host colonization through biofilm enhancement. Elife 11, e73010. doi:&#xa0;10.7554/eLife.73010</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.73010</ArticleId><ArticleId IdType="pmc">PMC8993218</ArticleId><ArticleId IdType="pubmed">35343438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellando-Randone S., Russo E., Venerito V., Matucci-Cerinic M., Iannone F., Tangaro S., et al. . (2021). Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an AI approach. J. Pers. Med. 11 (7), 625. doi:&#xa0;10.3390/jpm11070625</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11070625</ArticleId><ArticleId IdType="pmc">PMC8306274</ArticleId><ArticleId IdType="pubmed">34209167</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellocchi C., Fernandez-Ochoa A., Montanelli G., Vigone B., Santaniello A., Quirantes-Pine R., et al. . (2019). Identification of a shared microbiomic and metabolomic profile in systemic autoimmune diseases. J. Clin. Med. 8 (9), 1291. doi:&#xa0;10.3390/jcm8091291</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8091291</ArticleId><ArticleId IdType="pmc">PMC6780636</ArticleId><ArticleId IdType="pubmed">31450824</ArticleId></ArticleIdList></Reference><Reference><Citation>Berer K., Gerdes L. A., Cekanaviciute E., Jia X., Xiao L., Xia Z., et al. . (2017). Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc. Natl. Acad. Sci. U.S.A. 114 (40), 10719&#x2013;10724. doi:&#xa0;10.1073/pnas.1711233114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1711233114</ArticleId><ArticleId IdType="pmc">PMC5635914</ArticleId><ArticleId IdType="pubmed">28893994</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano-Ortiz A., Laborda-Illanes A., Plaza-Andrades I., Membrillo Del Pozo A., Villarrubia Cuadrado A., Rodriguez Calvo de Mora M., et al. . (2020). Connection between the gut microbiome, systemic inflammation, gut permeability and FOXP3 expression in patients with primary sjogren&#x2019;s syndrome. Int. J. Mol. Sci. 21 (22), 8733. doi:&#xa0;10.3390/ijms21228733</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228733</ArticleId><ArticleId IdType="pmc">PMC7699261</ArticleId><ArticleId IdType="pubmed">33228011</ArticleId></ArticleIdList></Reference><Reference><Citation>Cekanaviciute E., Yoo B. B., Runia T. F., Debelius J. W., Singh S., Nelson C. A., et al. . (2017). Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc. Natl. Acad. Sci. U.S.A. 114 (40), 10713&#x2013;10718. doi:&#xa0;10.1073/pnas.1711235114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1711235114</ArticleId><ArticleId IdType="pmc">PMC5635915</ArticleId><ArticleId IdType="pubmed">28893978</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D., Cao Y., Yu L., Tao Y., Zhou Y., Zhi Q., et al. . (2019). Characteristics and influencing factors of amyloid fibers in s. mutans biofilm. AMB Express 9 (1), 31. doi:&#xa0;10.1186/s13568-019-0753-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13568-019-0753-1</ArticleId><ArticleId IdType="pmc">PMC6395465</ArticleId><ArticleId IdType="pubmed">30820691</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Chia N., Kalari K. R., Yao J. Z., Novotna M., Paz Soldan M. M., et al. . (2016. a). Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci. Rep. 6, 28484. doi:&#xa0;10.1038/srep28484</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28484</ArticleId><ArticleId IdType="pmc">PMC4921909</ArticleId><ArticleId IdType="pubmed">27346372</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B. D., Jia X. M., Xu J. Y., Zhao L. D., Ji J. Y., Wu B. X., et al. . (2021). An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arthritis Rheumatol. 73 (2), 232&#x2013;243. doi:&#xa0;10.1002/art.41511</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41511</ArticleId><ArticleId IdType="pubmed">33124780</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Sun L., Zhang X. (2017). Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. J. Autoimmun 83, 31&#x2013;42. doi:&#xa0;10.1016/j.jaut.2017.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2017.03.009</ArticleId><ArticleId IdType="pubmed">28342734</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wright K., Davis J. M., Jeraldo P., Marietta E. V., Murray J., et al. . (2016. b). An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 8 (1), 43. doi:&#xa0;10.1186/s13073-016-0299-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-016-0299-7</ArticleId><ArticleId IdType="pmc">PMC4840970</ArticleId><ArticleId IdType="pubmed">27102666</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke J. (2020). Disease onset goes with its gut in RA. Nat. Rev. Rheumatol. 16 (7), 350. doi:&#xa0;10.1038/s41584-020-0436-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0436-y</ArticleId><ArticleId IdType="pubmed">32393827</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham M. W. (2019). Molecular mimicry, autoimmunity, and infection: The cross-reactive antigens of group a streptococci and their sequelae. Microbiol. Spectr. 7 (4), 1&#x2013;51. doi:&#xa0;10.1128/microbiolspec.GPP3-0045-2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.GPP3-0045-2018</ArticleId><ArticleId IdType="pmc">PMC6684244</ArticleId><ArticleId IdType="pubmed">31373269</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalile B., Van Oudenhove L., Vervliet B., Verbeke K. (2019). The role of short-chain fatty acids in microbiota-gut-brain communication. Nat. Rev. Gastroenterol. Hepatol. 16 (8), 461&#x2013;478. doi:&#xa0;10.1038/s41575-019-0157-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-019-0157-3</ArticleId><ArticleId IdType="pubmed">31123355</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca F., Shoenfeld Y. (2019). The microbiome in autoimmune diseases. Clin. Exp. Immunol. 195 (1), 74&#x2013;85. doi:&#xa0;10.1111/cei.13158</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13158</ArticleId><ArticleId IdType="pmc">PMC6300652</ArticleId><ArticleId IdType="pubmed">29920643</ArticleId></ArticleIdList></Reference><Reference><Citation>Dema B., Charles N. (2016). Autoantibodies in SLE: Specificities, isotypes and receptors. Antibodies (Basel) 5 (1), 2. doi:&#xa0;10.3390/antib5010002</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antib5010002</ArticleId><ArticleId IdType="pmc">PMC6698872</ArticleId><ArticleId IdType="pubmed">31557984</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinse G. E., Parks C. G., Weinberg C. R., Co C. A., Wilkerson J., Zeldin D. C., et al. . (2022). Increasing prevalence of antinuclear antibodies in the united states. Arthritis Rheumatol. 74 (12), 2032&#x2013;2041. doi:&#xa0;10.1002/art.42330</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42330</ArticleId><ArticleId IdType="pubmed">36054084</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Villar M., Hafler D. A. (2018). Regulatory T cells in autoimmune disease. Nat. Immunol. 19 (7), 665&#x2013;673. doi:&#xa0;10.1038/s41590-018-0120-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0120-4</ArticleId><ArticleId IdType="pmc">PMC7882196</ArticleId><ArticleId IdType="pubmed">29925983</ArticleId></ArticleIdList></Reference><Reference><Citation>Duscha A., Gisevius B., Hirschberg S., Yissachar N., Stangl G. I., Eilers E., et al. . (2020). Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell 180 (6), 1067&#x2013;1080 e1016. doi:&#xa0;10.1016/j.cell.2020.02.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.035</ArticleId><ArticleId IdType="pubmed">32160527</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauny M., Moulin D., D&#x2019;Amico F., Netter P., Petitpain N., Arnone D., et al. . (2020). Paradoxical gastrointestinal effects of interleukin-17 blockers. Ann. Rheum Dis. 79 (9), 1132&#x2013;1138. doi:&#xa0;10.1136/annrheumdis-2020-217927</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217927</ArticleId><ArticleId IdType="pubmed">32719044</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng W., Ao H., Peng C. (2018). Gut microbiota, short-chain fatty acids, and herbal medicines. Front. Pharmacol. 9. doi:&#xa0;10.3389/fphar.2018.01354</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.01354</ArticleId><ArticleId IdType="pmc">PMC6265305</ArticleId><ArticleId IdType="pubmed">30532706</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbes J. D., Chen C. Y., Knox N. C., Marrie R. A., El-Gabalawy H., de Kievit T., et al. . (2018). A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? Microbiome 6 (1), 221. doi:&#xa0;10.1186/s40168-018-0603-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-018-0603-4</ArticleId><ArticleId IdType="pmc">PMC6292067</ArticleId><ArticleId IdType="pubmed">30545401</ArticleId></ArticleIdList></Reference><Reference><Citation>Frazzei G., van Vollenhoven R. F., de Jong B. A., Siegelaar S. E., van Schaardenburg D. (2022). Preclinical autoimmune disease: A comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes. Front. Immunol. 13. doi:&#xa0;10.3389/fimmu.2022.899372</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.899372</ArticleId><ArticleId IdType="pmc">PMC9281565</ArticleId><ArticleId IdType="pubmed">35844538</ArticleId></ArticleIdList></Reference><Reference><Citation>Furusawa Y., Obata Y., Fukuda S., Endo T. A., Nakato G., Takahashi D., et al. . (2013). Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (7480), 446&#x2013;450. doi:&#xa0;10.1038/nature12721</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12721</ArticleId><ArticleId IdType="pubmed">24226770</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo P. M., Rapsinski G. J., Wilson R. P., Oppong G. O., Sriram U., Goulian M., et al. . (2015). Amyloid-DNA composites of bacterial biofilms stimulate autoimmunity. Immunity 42 (6), 1171&#x2013;1184. doi:&#xa0;10.1016/j.immuni.2015.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.06.002</ArticleId><ArticleId IdType="pmc">PMC4500125</ArticleId><ArticleId IdType="pubmed">26084027</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudier E., Rival M., Buisine M. P., Robineau I., Hoebler C. (2009). Butyrate enemas upregulate muc genes expression but decrease adherent mucus thickness in mice colon. Physiol. Res. 58 (1), 111&#x2013;119. doi:&#xa0;10.33549/physiolres.931271</Citation><ArticleIdList><ArticleId IdType="doi">10.33549/physiolres.931271</ArticleId><ArticleId IdType="pubmed">18198997</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiling T. M., Dehner C., Chen X., Hughes K., Iniguez A. J., Boccitto M., et al. . (2018). Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci. Transl. Med. 10 (434), eaan2306. doi:&#xa0;10.1126/scitranslmed.aan2306</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aan2306</ArticleId><ArticleId IdType="pmc">PMC5918293</ArticleId><ArticleId IdType="pubmed">29593104</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M., Wang H., Xu S., Zhuang Y., An J., Su C., et al. . (2020). Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut Microbes 11 (6), 1758&#x2013;1773. doi:&#xa0;10.1080/19490976.2020.1768644</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1768644</ArticleId><ArticleId IdType="pmc">PMC7524333</ArticleId><ArticleId IdType="pubmed">32507008</ArticleId></ArticleIdList></Reference><Reference><Citation>He J., Chan T., Hong X., Zheng F., Zhu C., Yin L., et al. . (2020). Microbiome and metabolome analyses reveal the disruption of lipid metabolism in systemic lupus erythematosus. Front. Immunol. 11. doi:&#xa0;10.3389/fimmu.2020.01703</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01703</ArticleId><ArticleId IdType="pmc">PMC7411142</ArticleId><ArticleId IdType="pubmed">32849599</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z., Shao T., Li H., Xie Z., Wen C. (2016). Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog. 8, 64. doi:&#xa0;10.1186/s13099-016-0146-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-016-0146-9</ArticleId><ArticleId IdType="pmc">PMC5146896</ArticleId><ArticleId IdType="pubmed">27980687</ArticleId></ArticleIdList></Reference><Reference><Citation>Healy B. C., Ali E. N., Guttmann C. R., Chitnis T., Glanz B. I., Buckle G., et al. . (2009). Smoking and disease progression in multiple sclerosis. Arch. Neurol. 66 (7), 858&#x2013;864. doi:&#xa0;10.1001/archneurol.2009.122</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2009.122</ArticleId><ArticleId IdType="pmc">PMC2754172</ArticleId><ArticleId IdType="pubmed">19597087</ArticleId></ArticleIdList></Reference><Reference><Citation>Henke M. T., Kenny D. J., Cassilly C. D., Vlamakis H., Xavier R. J., Clardy J. (2019). Ruminococcus gnavus, a member of the human gut microbiome associated with crohn&#x2019;s disease, produces an inflammatory polysaccharide. Proc. Natl. Acad. Sci. U.S.A. 116 (26), 12672&#x2013;12677. doi:&#xa0;10.1073/pnas.1904099116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1904099116</ArticleId><ArticleId IdType="pmc">PMC6601261</ArticleId><ArticleId IdType="pubmed">31182571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hevia A., Milani C., Lopez P., Cuervo A., Arboleya S., Duranti S., et al. . (2014). Intestinal dysbiosis associated with systemic lupus erythematosus. mBio 5 (5), e01548&#x2013;e01514. doi:&#xa0;10.1128/mBio.01548-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01548-14</ArticleId><ArticleId IdType="pmc">PMC4196225</ArticleId><ArticleId IdType="pubmed">25271284</ArticleId></ArticleIdList></Reference><Reference><Citation>Houtman T. A., Eckermann H. A., Smidt H., de Weerth C. (2022). Gut microbiota and BMI throughout childhood: The role of firmicutes, bacteroidetes, and short-chain fatty acid producers. Sci. Rep. 12 (1), 3140. doi:&#xa0;10.1038/s41598-022-07176-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07176-6</ArticleId><ArticleId IdType="pmc">PMC8873392</ArticleId><ArticleId IdType="pubmed">35210542</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangi S., Gandhi R., Cox L. M., Li N., von Glehn F., Yan R., et al. . (2016). Alterations of the human gut microbiome in multiple sclerosis. Nat. Commun. 7, 12015. doi:&#xa0;10.1038/ncomms12015</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12015</ArticleId><ArticleId IdType="pmc">PMC4931233</ArticleId><ArticleId IdType="pubmed">27352007</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y., Yu Y., Bai F., Wang L., Yang D., Zhang C., et al. . (2021). Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: Involvement of brain-gut axis. Microbiome 9 (1), 59. doi:&#xa0;10.1186/s40168-021-01007-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-021-01007-y</ArticleId><ArticleId IdType="pmc">PMC7937282</ArticleId><ArticleId IdType="pubmed">33678185</ArticleId></ArticleIdList></Reference><Reference><Citation>Jubair W. K., Hendrickson J. D., Severs E. L., Schulz H. M., Adhikari S., Ir D., et al. . (2018). Modulation of inflammatory arthritis in mice by gut microbiota through mucosal inflammation and autoantibody generation. Arthritis Rheumatol. 70 (8), 1220&#x2013;1233. doi:&#xa0;10.1002/art.40490</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40490</ArticleId><ArticleId IdType="pmc">PMC6105374</ArticleId><ArticleId IdType="pubmed">29534332</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Zeng M. Y., Nunez G. (2017). The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. Exp. Mol. Med. 49 (5), e339. doi:&#xa0;10.1038/emm.2017.24</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2017.24</ArticleId><ArticleId IdType="pmc">PMC5454439</ArticleId><ArticleId IdType="pubmed">28546562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingwell E., van der Kop M., Zhao Y., Shirani A., Zhu F., Oger J., et al. . (2012). Relative mortality and survival in multiple sclerosis: Findings from British Columbia, Canada. J. Neurol. Neurosurg. Psychiatry 83 (1), 61&#x2013;66. doi:&#xa0;10.1136/jnnp-2011-300616</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-300616</ArticleId><ArticleId IdType="pubmed">21865212</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishikawa T., Maeda Y., Nii T., Motooka D., Matsumoto Y., Matsushita M., et al. . (2020). Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population. Ann. Rheum Dis. 79 (1), 103&#x2013;111. doi:&#xa0;10.1136/annrheumdis-2019-215743</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215743</ArticleId><ArticleId IdType="pmc">PMC6937407</ArticleId><ArticleId IdType="pubmed">31699813</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu N., Okamoto K., Sawa S., Nakashima T., Oh-hora M., Kodama T., et al. . (2014). Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat. Med. 20 (1), 62&#x2013;68. doi:&#xa0;10.1038/nm.3432</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3432</ArticleId><ArticleId IdType="pubmed">24362934</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y. H., Choi S. J., Ji J. D., Song G. G. (2016). Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus 25 (7), 727&#x2013;734. doi:&#xa0;10.1177/0961203315627202</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315627202</ArticleId><ArticleId IdType="pubmed">26811368</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wang H. F., Li X., Li H. X., Zhang Q., Zhou H. W., et al. . (2019). Disordered intestinal microbes are associated with the activity of systemic lupus erythematosus. Clin. Sci. (Lond) 133 (7), 821&#x2013;838. doi:&#xa0;10.1042/CS20180841</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180841</ArticleId><ArticleId IdType="pubmed">30872359</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz B., Ali N., Bocklitz T., Rosch P., Popp J. (2020). Discrimination between pathogenic and non-pathogenic e. coli strains by means of raman microspectroscopy. Anal. Bioanal Chem. 412 (30), 8241&#x2013;8247. doi:&#xa0;10.1007/s00216-020-02957-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-020-02957-2</ArticleId><ArticleId IdType="pmc">PMC7680742</ArticleId><ArticleId IdType="pubmed">33033893</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X. M., Edwards M. R., Mu Q., Yu Y., Vieson M. D., Reilly C. M., et al. . (2018). Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl. Environ. Microbiol. 84 (4), e02288-17. doi:&#xa0;10.1128/AEM.02288-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02288-17</ArticleId><ArticleId IdType="pmc">PMC5795066</ArticleId><ArticleId IdType="pubmed">29196292</ArticleId></ArticleIdList></Reference><Reference><Citation>Machiels K., Joossens M., Sabino J., De Preter V., Arijs I., Eeckhaut V., et al. . (2014). A decrease of the butyrate-producing species roseburia hominis and faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63 (8), 1275&#x2013;1283. doi:&#xa0;10.1136/gutjnl-2013-304833</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2013-304833</ArticleId><ArticleId IdType="pubmed">24021287</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciel G., Crowson C. S., Matteson E. L., Cornec D. (2017). Incidence and mortality of physician-diagnosed primary sjogren syndrome: Time trends over a 40-year period in a population-based US cohort. Mayo Clin. Proc. 92 (5), 734&#x2013;743. doi:&#xa0;10.1016/j.mayocp.2017.01.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2017.01.020</ArticleId><ArticleId IdType="pmc">PMC5470777</ArticleId><ArticleId IdType="pubmed">28389066</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda Y., Kurakawa T., Umemoto E., Motooka D., Ito Y., Gotoh K., et al. . (2016). Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol. 68 (11), 2646&#x2013;2661. doi:&#xa0;10.1002/art.39783</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39783</ArticleId><ArticleId IdType="pubmed">27333153</ArticleId></ArticleIdList></Reference><Reference><Citation>Majka D. S., Holers V. M. (2006) Cigarette smoking and the risk of systemic lupus erythematosus and rheumatoid arthritis. Ann. Rheum Dis. 65 (5), 561&#x2013;563. doi:&#xa0;10.1136/ard.2005.046052</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2005.046052</ArticleId><ArticleId IdType="pmc">PMC1798134</ArticleId><ArticleId IdType="pubmed">16611864</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandl T., Marsal J., Olsson P., Ohlsson B., Andreasson K. (2017). Severe intestinal dysbiosis is prevalent in primary sjogren&#x2019;s syndrome and is associated with systemic disease activity. Arthritis Res. Ther. 19 (1), 237. doi:&#xa0;10.1186/s13075-017-1446-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-017-1446-2</ArticleId><ArticleId IdType="pmc">PMC5655865</ArticleId><ArticleId IdType="pubmed">29065905</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto N., Salam M. A., Watanabe H., Amagasa T., Senpuku H. (2004). Role of gene E2f1 in susceptibility to bacterial adherence of oral streptococci to tooth surfaces in mice. Oral. Microbiol. Immunol. 19 (4), 270&#x2013;276. doi:&#xa0;10.1111/j.1399-302X.2004.00151.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-302X.2004.00151.x</ArticleId><ArticleId IdType="pubmed">15209999</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuoka T., Hosomi K., Park J., Goto Y., Nishimura M., Maruyama S., et al. . (2022). Relationships between barley consumption and gut microbiome characteristics in a healthy Japanese population: a cross-sectional study. BMC Nutr. 8 (1), 23. doi:&#xa0;10.1186/s40795-022-00500-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40795-022-00500-3</ArticleId><ArticleId IdType="pmc">PMC8919566</ArticleId><ArticleId IdType="pubmed">35287729</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez R., Watane A., Farhangi M., Cavuoto K. M., Leith T., Budree S., et al. . (2020). Gut microbial dysbiosis in individuals with sjogren&#x2019;s syndrome. Microb. Cell Fact 19 (1), 90. doi:&#xa0;10.1186/s12934-020-01348-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-020-01348-7</ArticleId><ArticleId IdType="pmc">PMC7158097</ArticleId><ArticleId IdType="pubmed">32293464</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel S., Leclerc M., Martin R., Chain F., Lenoir M., Raguideau S., et al. . (2015). Identification of metabolic signatures linked to anti-inflammatory effects of faecalibacterium prausnitzii. mBio 6 (2), e00300-15. doi:&#xa0;10.1128/mBio.00300-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00300-15</ArticleId><ArticleId IdType="pmc">PMC4453580</ArticleId><ArticleId IdType="pubmed">25900655</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake S., Kim S., Suda W., Oshima K., Nakamura M., Matsuoka T., et al. . (2015). Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PloS One 10 (9), e0137429. doi:&#xa0;10.1371/journal.pone.0137429</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0137429</ArticleId><ArticleId IdType="pmc">PMC4569432</ArticleId><ArticleId IdType="pubmed">26367776</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon J., Choi S. H., Yoon C. H., Kim M. K. (2020. a). Gut dysbiosis is prevailing in sjogren&#x2019;s syndrome and is related to dry eye severity. PloS One 15 (2), e0229029. doi:&#xa0;10.1371/journal.pone.0229029</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0229029</ArticleId><ArticleId IdType="pmc">PMC7021297</ArticleId><ArticleId IdType="pubmed">32059038</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon J., Yoon C. H., Choi S. H., Kim M. K. (2020. b). Can gut microbiota affect dry eye syndrome? Int. J. Mol. Sci. 21 (22), 8443. doi:&#xa0;10.3390/ijms21228443</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228443</ArticleId><ArticleId IdType="pmc">PMC7697210</ArticleId><ArticleId IdType="pubmed">33182758</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser T., Akg&#xfc;n K., Proschmann U., Sellner J., Ziemssen T. (2020). The role of TH17 cells in multiple sclerosis: Therapeutic implications. Autoimmun Rev. 19 (10), 102647. doi:&#xa0;10.1016/j.autrev.2020.102647</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102647</ArticleId><ArticleId IdType="pubmed">32801039</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowry E. M., Waubant E., McCulloch C. E., Okuda D. T., Evangelista A. A., Lincoln R. R., et al. . (2012). Vitamin d status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann. Neurol. 72 (2), 234&#x2013;240. doi:&#xa0;10.1002/ana.23591</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23591</ArticleId><ArticleId IdType="pmc">PMC3430977</ArticleId><ArticleId IdType="pubmed">22926855</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao-Kitamoto H., Kamada N. (2017). Host-microbial cross-talk in inflammatory bowel disease. Immune Netw. 17 (1), 1&#x2013;12. doi:&#xa0;10.4110/in.2017.17.1.1</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2017.17.1.1</ArticleId><ArticleId IdType="pmc">PMC5334117</ArticleId><ArticleId IdType="pubmed">28261015</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikitakis N. G., Papaioannou W., Sakkas L. I., Kousvelari E. (2017). The autoimmunity-oral microbiome connection. Oral. Dis. 23 (7), 828&#x2013;839. doi:&#xa0;10.1111/odi.12589</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.12589</ArticleId><ArticleId IdType="pubmed">27717092</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Callaghan A., van Sinderen D. (2016). Bifidobacteria and their role as members of the human gut microbiota. Front. Microbiol. 7. doi:&#xa0;10.3389/fmicb.2016.00925</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00925</ArticleId><ArticleId IdType="pmc">PMC4908950</ArticleId><ArticleId IdType="pubmed">27379055</ArticleId></ArticleIdList></Reference><Reference><Citation>Okumura S., Konishi Y., Narukawa M., Sugiura Y., Yoshimoto S., Arai Y., et al. . (2021). Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion. Nat. Commun. 12 (1), 5674. doi:&#xa0;10.1038/s41467-021-25965-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25965-x</ArticleId><ArticleId IdType="pmc">PMC8479117</ArticleId><ArticleId IdType="pubmed">34584098</ArticleId></ArticleIdList></Reference><Reference><Citation>Omenetti S., Bussi C., Metidji A., Iseppon A., Lee S., Tolaini M., et al. . (2019). The intestine harbors functionally distinct homeostatic tissue-resident and inflammatory Th17 cells. Immunity 51 (1), 77&#x2013;89 e76. doi:&#xa0;10.1016/j.immuni.2019.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.05.004</ArticleId><ArticleId IdType="pmc">PMC6642154</ArticleId><ArticleId IdType="pubmed">31229354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordonez-Canizares M. C., Mena-Vazquez N., Redondo-Rodriguez R., Manrique-Arija S., Jimenez-Nunez F. G., Urena-Garnica I., et al. . (2022). Frequency of polyautoimmunity in patients with rheumatoid arthritis and systemic lupus erythematosus. J. Clin. Rheumatol. 28 (1), e38&#x2013;e43. doi:&#xa0;10.1097/RHU.0000000000001574</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000001574</ArticleId><ArticleId IdType="pubmed">32956154</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmela C., Chevarin C., Xu Z., Torres J., Sevrin G., Hirten R., et al. . (2018). Adherent-invasive escherichia coli in inflammatory bowel disease. Gut 67 (3), 574&#x2013;587. doi:&#xa0;10.1136/gutjnl-2017-314903</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2017-314903</ArticleId><ArticleId IdType="pubmed">29141957</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Goergen C. J., HogenEsch H., Kim C. H. (2016). Chronically elevated levels of short-chain fatty acids induce T cell-mediated ureteritis and hydronephrosis. J. Immunol. 196 (5), 2388&#x2013;2400. doi:&#xa0;10.4049/jimmunol.1502046</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1502046</ArticleId><ArticleId IdType="pmc">PMC4761537</ArticleId><ArticleId IdType="pubmed">26819206</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Kim C. H. (2021). Regulation of common neurological disorders by gut microbial metabolites. Exp. Mol. Med. 53 (12), 1821&#x2013;1833. doi:&#xa0;10.1038/s12276-021-00703-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00703-x</ArticleId><ArticleId IdType="pmc">PMC8741890</ArticleId><ArticleId IdType="pubmed">34857900</ArticleId></ArticleIdList></Reference><Reference><Citation>Petitdemange A., Blaess J., Sibilia J., Felten R., Arnaud L. (2020). Shared development of targeted therapies among autoimmune and inflammatory diseases: A systematic repurposing analysis. Ther. Adv. Musculoskelet Dis. 12, 1759720X20969261. doi:&#xa0;10.1177/1759720X20969261</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X20969261</ArticleId><ArticleId IdType="pmc">PMC7747103</ArticleId><ArticleId IdType="pubmed">33403021</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu C. C., Caricchio R., Gallucci S. (2019). Triggers of autoimmunity: The role of bacterial infections in the extracellular exposure of lupus nuclear autoantigens. Front. Immunol. 10. doi:&#xa0;10.3389/fimmu.2019.02608</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02608</ArticleId><ArticleId IdType="pmc">PMC6857005</ArticleId><ArticleId IdType="pubmed">31781110</ArticleId></ArticleIdList></Reference><Reference><Citation>Quevrain E., Maubert M. A., Michon C., Chain F., Marquant R., Tailhades J., et al. . (2016). Identification of an anti-inflammatory protein from faecalibacterium prausnitzii, a commensal bacterium deficient in crohn&#x2019;s disease. Gut 65 (3), 415&#x2013;425. doi:&#xa0;10.1136/gutjnl-2014-307649</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2014-307649</ArticleId><ArticleId IdType="pmc">PMC5136800</ArticleId><ArticleId IdType="pubmed">26045134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindra N., Sadashiva N., Mahadevan A., Bhat D. I., Saini J. (2018). Central nervous system actinomycosis-a clinicoradiologic and histopathologic analysis. World Neurosurg. 116, e362&#x2013;e370. doi:&#xa0;10.1016/j.wneu.2018.04.205</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2018.04.205</ArticleId><ArticleId IdType="pubmed">29751182</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi E., Consonni A., Cordiglieri C., Sacco G., Crasa C., Fontana A., et al. . (2019). Therapeutic effect of bifidobacterium administration on experimental autoimmune myasthenia gravis in Lewis rats. Front. Immunol. 10. doi:&#xa0;10.3389/fimmu.2019.02949</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02949</ArticleId><ArticleId IdType="pmc">PMC6951413</ArticleId><ArticleId IdType="pubmed">31956324</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert M., Miossec P. (2020). Interleukin-17 and lupus: enough to be a target? For which patients? Lupus 29 (1), 6&#x2013;14. doi:&#xa0;10.1177/0961203319891243</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319891243</ArticleId><ArticleId IdType="pubmed">31791181</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues G. S. P., Cayres L. C. F., Goncalves F. P., Takaoka N. N. C., Lengert A. H., Tansini A., et al. . (2019). Detection of increased relative expression units of bacteroides and prevotella, and decreased clostridium leptum in stool samples from Brazilian rheumatoid arthritis patients: A pilot study. Microorganisms 7 (10), 413. doi:&#xa0;10.3390/microorganisms7100413</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms7100413</ArticleId><ArticleId IdType="pmc">PMC6843655</ArticleId><ArticleId IdType="pubmed">31581593</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-Villarraga A., Amaya-Amaya J., Rodriguez-Rodriguez A., Mantilla R. D., Anaya J. M. (2012). Introducing polyautoimmunity: Secondary autoimmune diseases no longer exist. Autoimmune Dis. 2012, 254319. doi:&#xa0;10.1155/2012/254319</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/254319</ArticleId><ArticleId IdType="pmc">PMC3290803</ArticleId><ArticleId IdType="pubmed">22454759</ArticleId></ArticleIdList></Reference><Reference><Citation>Scher J. U., Sczesnak A., Longman R. S., Segata N., Ubeda C., Bielski C., et al. . (2013). Expansion of intestinal prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2, e01202. doi:&#xa0;10.7554/eLife.01202</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.01202</ArticleId><ArticleId IdType="pmc">PMC3816614</ArticleId><ArticleId IdType="pubmed">24192039</ArticleId></ArticleIdList></Reference><Reference><Citation>Schett G., Elewaut D., McInnes I. B., Dayer J. M., Neurath M. F. (2013). How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy. Nat. Med. 19 (7), 822&#x2013;824. doi:&#xa0;10.1038/nm.3260</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3260</ArticleId><ArticleId IdType="pubmed">23836224</ArticleId></ArticleIdList></Reference><Reference><Citation>Silman A. J., MacGregor A. J., Thomson W., Holligan S., Carthy D., Farhan A., et al. . (1993). Twin concordance rates for rheumatoid arthritis: Results from a nationwide study. Br. J. Rheumatol. 32 (10), 903&#x2013;907. doi:&#xa0;10.1093/rheumatology/32.10.903</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/32.10.903</ArticleId><ArticleId IdType="pubmed">8402000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Chen Q., Lin P., Xu R., He D., Ji W., et al. . (2019). Characteristics of gut microbiota in patients with rheumatoid arthritis in shanghai, China. Front. Cell Infect. Microbiol. 9. doi:&#xa0;10.3389/fcimb.2019.00369</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00369</ArticleId><ArticleId IdType="pmc">PMC6819506</ArticleId><ArticleId IdType="pubmed">31709198</ArticleId></ArticleIdList></Reference><Reference><Citation>Takewaki D., Suda W., Sato W., Takayasu L., Kumar N., Kimura K., et al. . (2020). Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 117 (36), 22402&#x2013;22412. doi:&#xa0;10.1073/pnas.2011703117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2011703117</ArticleId><ArticleId IdType="pmc">PMC7486801</ArticleId><ArticleId IdType="pubmed">32839304</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong Y., Zheng L., Qing P., Zhao H., Li Y., Su L., et al. . (2019). Oral microbiota perturbations are linked to high risk for rheumatoid arthritis. Front. Cell Infect. Microbiol. 9. doi:&#xa0;10.3389/fcimb.2019.00475</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00475</ArticleId><ArticleId IdType="pmc">PMC6987375</ArticleId><ArticleId IdType="pubmed">32039051</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremlett H., Fadrosh D. W., Faruqi A. A., Zhu F., Hart J., Roalstad S., et al. . (2016). Gut microbiota in early pediatric multiple sclerosis: A case-control study. Eur. J. Neurol. 23 (8), 1308&#x2013;1321. doi:&#xa0;10.1111/ene.13026</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13026</ArticleId><ArticleId IdType="pmc">PMC4955679</ArticleId><ArticleId IdType="pubmed">27176462</ArticleId></ArticleIdList></Reference><Reference><Citation>Valour F., Senechal A., Dupieux C., Karsenty J., Lustig S., Breton P., et al. . (2014). Actinomycosis: Etiology, clinical features, diagnosis, treatment, and management. Infect. Drug Resist. 7, 183&#x2013;197. doi:&#xa0;10.2147/IDR.S39601</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S39601</ArticleId><ArticleId IdType="pmc">PMC4094581</ArticleId><ArticleId IdType="pubmed">25045274</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Hoek J., Boshuizen H. C., Roorda L. D., Tijhuis G. J., Nurmohamed M. T., van den Bos G. A., et al. . (2017). Mortality in patients with rheumatoid arthritis: A 15-year prospective cohort study. Rheumatol. Int. 37 (4), 487&#x2013;493. doi:&#xa0;10.1007/s00296-016-3638-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-016-3638-5</ArticleId><ArticleId IdType="pmc">PMC5357293</ArticleId><ArticleId IdType="pubmed">28032180</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Meulen T. A., Harmsen H. J. M., Vila A. V., Kurilshikov A., Liefers S. C., Zhernakova A., et al. . (2019). Shared gut, but distinct oral microbiota composition in primary sjogren&#x2019;s syndrome and systemic lupus erythematosus. J. Autoimmun 97, 77&#x2013;87. doi:&#xa0;10.1016/j.jaut.2018.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.009</ArticleId><ArticleId IdType="pubmed">30416033</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Wiele T., Van Praet J. T., Marzorati M., Drennan M. B., Elewaut D. (2016). How the microbiota shapes rheumatic diseases. Nat. Rev. Rheumatol. 12 (7), 398&#x2013;411. doi:&#xa0;10.1038/nrrheum.2016.85</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.85</ArticleId><ArticleId IdType="pubmed">27305853</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatanen T., Kostic A. D., d&#x2019;Hennezel E., Siljander H., Franzosa E. A., Yassour M., et al. . (2016). Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165 (4), 842&#x2013;853. doi:&#xa0;10.1016/j.cell.2016.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.04.007</ArticleId><ArticleId IdType="pmc">PMC4950857</ArticleId><ArticleId IdType="pubmed">27133167</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijay A., Valdes A. M. (2021). Role of the gut microbiome in chronic diseases: A narrative review. Eur. J. Clin. Nutr 76, 489&#x2013;501. doi:&#xa0;10.1038/s41430-021-00991-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-021-00991-6</ArticleId><ArticleId IdType="pmc">PMC8477631</ArticleId><ArticleId IdType="pubmed">34584224</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Chen H., Wen X., Mu J., Sun M., Song X., et al. . (2021). The efficacy of fecal microbiota transplantation in experimental autoimmune encephalomyelitis: Transcriptome and gut microbiota profiling. J. Immunol. Res. 2021, 4400428. doi:&#xa0;10.1155/2021/4400428</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/4400428</ArticleId><ArticleId IdType="pmc">PMC8687821</ArticleId><ArticleId IdType="pubmed">34938813</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen M., Liu T., Zhao M., Dang X., Feng S., Ding X., et al. . (2021). Correlation analysis between gut microbiota and metabolites in children with systemic lupus erythematosus. J. Immunol. Res. 2021, 5579608. doi:&#xa0;10.1155/2021/5579608</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5579608</ArticleId><ArticleId IdType="pmc">PMC8325587</ArticleId><ArticleId IdType="pubmed">34341764</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Zhang M., Zhang W., Liu X., Zheng W., Jiang X. (2020). Gold nanoclusters-coated orthodontic devices can inhibit the formation of streptococcus mutans biofilm. ACS Biomater. Sci. Eng. 6 (2), 1239&#x2013;1246. doi:&#xa0;10.1021/acsbiomaterials.9b01647</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsbiomaterials.9b01647</ArticleId><ArticleId IdType="pubmed">33464842</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q., Ni J. J., Han B. X., Yan S. S., Wei X. T., Feng G. J., et al. . (2021). Causal relationship between gut microbiota and autoimmune diseases: A two-sample mendelian randomization study. Front. Immunol. 12. doi:&#xa0;10.3389/fimmu.2021.746998</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746998</ArticleId><ArticleId IdType="pmc">PMC8819003</ArticleId><ArticleId IdType="pubmed">35140703</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P., Qian F. Y., Zhang M. F., Xu A. L., Wang X., Jiang B. P., et al. . (2019). Th17 cell pathogenicity and plasticity in rheumatoid arthritis. J. Leukoc. Biol. 106 (6), 1233&#x2013;1240. doi:&#xa0;10.1002/JLB.4RU0619-197R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4RU0619-197R</ArticleId><ArticleId IdType="pubmed">31497905</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao S., Zhao Z., Wang W., Liu X. (2021). Bifidobacterium longum: Protection against inflammatory bowel disease. J. Immunol. Res. 2021, 8030297. doi:&#xa0;10.1155/2021/8030297</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8030297</ArticleId><ArticleId IdType="pmc">PMC8324359</ArticleId><ArticleId IdType="pubmed">34337079</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y., Choi S. C., Xu Z., Perry D. J., Seay H., Croker B. P., et al. . (2015). Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med. 7 (274), 274ra218. doi:&#xa0;10.1126/scitranslmed.aaa0835</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa0835</ArticleId><ArticleId IdType="pmc">PMC5292723</ArticleId><ArticleId IdType="pubmed">25673763</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Q., Junli G., Liu X., Chen C., Sun X., Li H., et al. . (2019). Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis. Neurochem. Int. 129, 104468. doi:&#xa0;10.1016/j.neuint.2019.104468</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2019.104468</ArticleId><ArticleId IdType="pubmed">31108132</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S. X., Wang J., Chen J. W., Zhang M. X., Zhang Y. F., Hu F. Y., et al. . (2021). The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus. Ann. Rheum Dis. 80 (11), e177. doi:&#xa0;10.1136/annrheumdis-2019-216504</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-216504</ArticleId><ArticleId IdType="pubmed">31732515</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Zhang D., Jia H., Feng Q., Wang D., Liang D., et al. . (2015). The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21 (8), 895&#x2013;905. doi:&#xa0;10.1038/nm.3914</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3914</ArticleId><ArticleId IdType="pubmed">26214836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Xu H., Xu J., Guo X., Zhao H., Chen Y., et al. . (2021). F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis. AMB Express 11 (1), 33. doi:&#xa0;10.1186/s13568-021-01197-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13568-021-01197-6</ArticleId><ArticleId IdType="pmc">PMC7914335</ArticleId><ArticleId IdType="pubmed">33641084</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>